Business: Ahmedabad-based Zydus Lifesciences reported a 30.66 per cent year-on-year rise in profit after tax (PAT) to Rs 1,482.5 crore during the first quarter of FY2024-25 ended June 30. Zydus’ revenue from operations grew 20.79 per cent year-on-year to Rs 6,207.5 crore. On a sequential basis, the company showed a 12.17 per cent growth in revenue, with PAT also growing by 19.27 per cent. Ebitda (earnings before interest, tax, depreciation and amortization) margin grew 38.4 per cent year-on-year to Rs 2,084 crore. Speaking on the results, Sharvil Patel, Managing Director, Zydus Lifesciences, said, “Continued growth momentum across our businesses, as well as enhanced profitability drove our strong Q1 performance. The execution success of our differentiated pipeline in the US and the outperformance of our India geography business were particularly noteworthy. Focusing on quality excellence, we continue to align our processes and strengthen compliance.”
Zydus Lifesciences Q1 FY25 results: Know PAT, revenue growth?
